No quarterly revenue total was found in HEARTBEAM, INC.'s SEC filings.
Heartbeam, Inc. (BEATW) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$3.6 million.
Revenue
—
Net income
$-5.04M
-1.3% vs year-ago quarter
Operating cash flow
$-3.34M
+3.0% vs year-ago quarter
Free cash flow
$-3.59M
-1.2% vs year-ago quarter
EPS
$-0.10
+33.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
56.35M
+64.2% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- BEATW (Nasdaq), BEAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Santa Clara, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1779372
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$5.1M | -$4.7M | -$5.3M | -$5.3M | -$5.0M |
| Net income | -$5.0M | -$4.7M | -$5.3M | -$5.3M | -$5.0M |
| Diluted EPS | -$0.10 | -$0.12 | -$0.15 | -$0.15 | -$0.15 |
| Operating cash flow | -$3.3M | -$3.6M | -$2.9M | -$3.2M | -$3.4M |
| Free cash flow | -$3.6M | -$3.9M | -$3.3M | -$3.2M | -$3.5M |
| Total assets | $10.6M | $3.9M | $5.8M | $2.9M | $6.0M |
| Total liabilities | $2.5M | $3.3M | $3.2M | $2.5M | $1.8M |
| Stockholders' equity | $8.2M | $635,000 | $2.6M | $406,000 | $4.2M |
| Cash and investments | $8.7M | $2.0M | $4.4M | $1.9M | $3.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Aug 6, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 24, 2026 | Jun 18, 2026 |
All 271 Heartbeam, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.